BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 14872505)

  • 1. Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.
    Hawkins PN; Lachmann HJ; Aganna E; McDermott MF
    Arthritis Rheum; 2004 Feb; 50(2):607-12. PubMed ID: 14872505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis.
    Aganna E; Martinon F; Hawkins PN; Ross JB; Swan DC; Booth DR; Lachmann HJ; Bybee A; Gaudet R; Woo P; Feighery C; Cotter FE; Thome M; Hitman GA; Tschopp J; McDermott MF
    Arthritis Rheum; 2002 Sep; 46(9):2445-52. PubMed ID: 12355493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and genetic heterogeneity among Spanish patients with recurrent autoinflammatory syndromes associated with the CIAS1/PYPAF1/NALP3 gene.
    Aróstegui JI; Aldea A; Modesto C; Rua MJ; Argüelles F; González-Enseñat MA; Ramos E; Rius J; Plaza S; Vives J; Yagüe J
    Arthritis Rheum; 2004 Dec; 50(12):4045-50. PubMed ID: 15593220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Muckle-Wells syndrome: a rare periodic fever syndrome].
    Appels CW; Kloppenburg M
    Ned Tijdschr Geneeskd; 2006 Jul; 150(29):1628-31. PubMed ID: 16901068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.
    Aksentijevich I; Nowak M; Mallah M; Chae JJ; Watford WT; Hofmann SR; Stein L; Russo R; Goldsmith D; Dent P; Rosenberg HF; Austin F; Remmers EF; Balow JE; Rosenzweig S; Komarow H; Shoham NG; Wood G; Jones J; Mangra N; Carrero H; Adams BS; Moore TL; Schikler K; Hoffman H; Lovell DJ; Lipnick R; Barron K; O'Shea JJ; Kastner DL; Goldbach-Mansky R
    Arthritis Rheum; 2002 Dec; 46(12):3340-8. PubMed ID: 12483741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New CIAS1 mutation and anakinra efficacy in overlapping of Muckle-Wells and familial cold autoinflammatory syndromes.
    Maksimovic L; Stirnemann J; Caux F; Ravet N; Rouaghe S; Cuisset L; Letellier E; Grateau G; Morin AS; Fain O
    Rheumatology (Oxford); 2008 Mar; 47(3):309-10. PubMed ID: 18174231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hearing improvement in a patient with variant Muckle-Wells syndrome in response to interleukin 1 receptor antagonism.
    Rynne M; Maclean C; Bybee A; McDermott MF; Emery P
    Ann Rheum Dis; 2006 Apr; 65(4):533-4. PubMed ID: 16531551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Successful treatment of clinical manifestations of Muckle-Wells syndrome with anakinra].
    Dybowski F; Jakobs B; Altmeyer P; Braun J
    Dtsch Med Wochenschr; 2006 Aug; 131(34-35):1863-6. PubMed ID: 16915547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.
    Hedrich CM; Fiebig B; Sallmann S; Bruck N; Hahn G; Roesler J; Roesen-Wolff A; Heubner G; Gahr M
    Scand J Rheumatol; 2008; 37(5):385-9. PubMed ID: 18609262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryopyrin-associated periodic syndromes and autoinflammation.
    Shinkai K; McCalmont TH; Leslie KS
    Clin Exp Dermatol; 2008 Jan; 33(1):1-9. PubMed ID: 17927785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome.
    Kuemmerle-Deschner JB; Tyrrell PN; Koetter I; Wittkowski H; Bialkowski A; Tzaribachev N; Lohse P; Koitchev A; Deuter C; Foell D; Benseler SM
    Arthritis Rheum; 2011 Mar; 63(3):840-9. PubMed ID: 21360513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Mutation negative" familial cold autoinflammatory syndrome (FCAS) in an 8-year-old boy: clinical course and functional studies.
    Hedrich CM; Bruck N; Paul D; Hahn G; Gahr M; Rösen-Wolff A
    Rheumatol Int; 2012 Sep; 32(9):2629-36. PubMed ID: 21833523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery from deafness in a patient with Muckle-Wells syndrome treated with anakinra.
    Mirault T; Launay D; Cuisset L; Hachulla E; Lambert M; Queyrel V; Quemeneur T; Morell-Dubois S; Hatron PY
    Arthritis Rheum; 2006 May; 54(5):1697-700. PubMed ID: 16646042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations.
    Gattorno M; Tassi S; Carta S; Delfino L; Ferlito F; Pelagatti MA; D'Osualdo A; Buoncompagni A; Alpigiani MG; Alessio M; Martini A; Rubartelli A
    Arthritis Rheum; 2007 Sep; 56(9):3138-48. PubMed ID: 17763411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A variant Muckle-Wells syndrome with a novel mutation in CIAS1 gene responding to anakinra.
    Dalgic B; Egritas O; Sari S; Cuisset L
    Pediatr Nephrol; 2007 Sep; 22(9):1391-4. PubMed ID: 17486372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anakinra improves sensory deafness in a Japanese patient with Muckle-Wells syndrome, possibly by inhibiting the cryopyrin inflammasome.
    Yamazaki T; Masumoto J; Agematsu K; Sawai N; Kobayashi S; Shigemura T; Yasui K; Koike K
    Arthritis Rheum; 2008 Mar; 58(3):864-8. PubMed ID: 18311804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.
    Neven B; Marvillet I; Terrada C; Ferster A; Boddaert N; Couloignier V; Pinto G; Pagnier A; Bodemer C; Bodaghi B; Tardieu M; Prieur AM; Quartier P
    Arthritis Rheum; 2010 Jan; 62(1):258-67. PubMed ID: 20039428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome.
    Hoffman HM; Mueller JL; Broide DH; Wanderer AA; Kolodner RD
    Nat Genet; 2001 Nov; 29(3):301-5. PubMed ID: 11687797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel missense mutation in CIAS1 encoding the pyrin-like protein, cryopyrin, causes familial cold autoinflammatory syndrome in a family of Ethiopian origin.
    Shalev SA; Sprecher E; Indelman M; Hujirat Y; Bergman R; Rottem M
    Int Arch Allergy Immunol; 2007; 143(3):190-3. PubMed ID: 17284928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NLRP3 E311K mutation in a large family with Muckle-Wells syndrome--description of a heterogeneous phenotype and response to treatment.
    Kuemmerle-Deschner JB; Lohse P; Koetter I; Dannecker GE; Reess F; Ummenhofer K; Koch S; Tzaribachev N; Bialkowski A; Benseler SM
    Arthritis Res Ther; 2011; 13(6):R196. PubMed ID: 22146561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.